|ECR 2019 / C-0221||
|Adverse events of Targeted Anticancer Therapies: what the radiologist should know.|
Understanding molecular mechanisms of TAT and recognizing their AE is essential to guide appropriate treatment and avoid potential imaging pitfalls that could be mistaken for cancer progression. As our knowledge about molecular biology increases, so will drugs and their AE. A close communication between the oncologist and radiologist is indispensable in our day-to-day work.
Thematically related posters
ECR 2019 / C-3781
New drugs, new toxicities: recognizing the radiological spectrum of cancer immunotherapy adverse effects